You can count Seres Health among the wave of biotech companies starting the year with a big new round of venture cash. The Cambridge, MA-based biotech–which has set out to make its reputation in the trendy new microbiome space–said today that it raised $65 million from Nestle Health Science.

…read more

Source: The biotech blitz: Seres Health lands $65M for PhIII C. diff push


0 No comments